» Articles » PMID: 22079179

Evolution of Neutrophil Apoptosis in Septic Shock Survivors and Nonsurvivors

Overview
Journal J Crit Care
Specialty Critical Care
Date 2011 Nov 15
PMID 22079179
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The aims were to analyze the temporal evolution of neutrophil apoptosis, to determine the differences in neutrophil apoptosis among 28-day survivors and nonsurvivors, and to evaluate the use of neutrophil apoptosis as a predictor of mortality in patients with septic shock.

Materials And Methods: Prospective multicenter observational study carried out between July 2006 and June 2009. The staining solution study included 80 patients with septic shock and 25 healthy volunteers. Neutrophil apoptosis was assessed by fluorescein isothiocyanate (FITC)-conjugated annexin V and aminoactinomycin D staining.

Results: The percentage of neutrophil apoptosis was significantly decreased at 24 hours, 5 days, and 12 days after the diagnosis of septic shock (14.8% ± 13.4%, 13.4% ± 8.4%, and 15.4% ± 12.8%, respectively; P < .0001) compared with the control group (37.6% ± 12.8%). The difference in apoptosis between 28-day surviving and nonsurviving patients was nonsignificant (P > .05). The mortality rate at 28 days was 53.7%. The crude hazard ratio for mortality in patients with septic shock did not differ according to the percentage of apoptosis (hazard ratio, 1.006; 95% confidence interval, 0.98-1.03; P = .60).

Conclusions: During the first 12 days of septic shock development, the level of neutrophil apoptosis decreases and does not recover normal values. No differences were observed between surviving and nonsurviving patients.

Citing Articles

Application of neutrophil-to-lymphocyte-to-monocyte ratio in predicting mortality risk in adult patients with septic shock: A retrospective cohort study conducted at a single center.

Lin X, Zhang L, Wang Y, Huang T, Lin X, Hong X Heliyon. 2024; 10(7):e28809.

PMID: 38596065 PMC: 11002270. DOI: 10.1016/j.heliyon.2024.e28809.


Advances and Challenges in Sepsis Management: Modern Tools and Future Directions.

Santacroce E, DAngerio M, Ciobanu A, Masini L, Lo Tartaro D, Coloretti I Cells. 2024; 13(5.

PMID: 38474403 PMC: 10931424. DOI: 10.3390/cells13050439.


Sepsis in elderly patients: the role of neutrophils in pathophysiology and therapy.

Ramoni D, Tirandi A, Montecucco F, Liberale L Intern Emerg Med. 2024; 19(4):901-917.

PMID: 38294676 PMC: 11186952. DOI: 10.1007/s11739-023-03515-1.


Identification of key biomarkers in neonatal sepsis by integrated bioinformatics analysis and clinical validation.

Yan R, Zhou T Heliyon. 2022; 8(11):e11634.

PMID: 36411922 PMC: 9674918. DOI: 10.1016/j.heliyon.2022.e11634.


The Interplay between Host Defense, Infection, and Clinical Status in Septic Patients: A Narrative Review.

Lazzaro A, De Girolamo G, Filippi V, Innocenti G, Santinelli L, Ceccarelli G Int J Mol Sci. 2022; 23(2).

PMID: 35054993 PMC: 8776148. DOI: 10.3390/ijms23020803.